Previous 10 | Next 10 |
home / stock / awkn:cc / awkn:cc news
Annual Revenue Increased by 534% Toronto, Ontario--(Newsfile Corp. - April 28, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), annou...
IIROC Trade Resumption - AWKN Canada NewsWire TORONTO , April 26, 2023 /CNW/ - Trading resumes in: Company: AWAKN LIFE SCIENCES CORP. NEO Exchange Symbol: AWKN All Issues: Yes Resumption (ET): 9:30 AM IIROC can make a decision to impose a temp...
Toronto, Ontario--(Newsfile Corp. - April 26, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (the " Company "), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), is pleased to announce a non-brokered p...
IIROC Trading Halt - AWKN Canada NewsWire TORONTO , April 26, 2023 /CNW/ - The following issues have been halted by IIROC: Company: AWAKN LIFE SCIENCES CORP. NEO Exchange Symbol : AWKN All Issues: Yes Reason: Pending News Halt Time (ET): 8:03 AM...
Phase III Trial Will Assess Ketamine-Assisted Therapy for the Treatment of Severe Alcohol Use Disorder Toronto, Ontario--(Newsfile Corp. - April 18, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing therapeutics to treat addicti...
Toronto, Ontario--(Newsfile Corp. - April 12, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), is today providing a corporate update. Dr. Be...
Partnership is Awakn's first with a dedicated addiction treatment clinic, Ken Starr MD Wellness Group Toronto, Ontario--(Newsfile Corp. - February 28, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing therapeutics to treat addic...
Awakn Will License its Protocols for Treating Addiction and Mental Health to a Healthcare Consortium to Help Accelerate Their Development of a Chain of Clinics in Portugal Toronto, Ontario--(Newsfile Corp. - February 21, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("A...
Awakn Clinics Trondheim is its second clinic in Norway Toronto, Ontario--(Newsfile Corp. - February 14, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Diso...
Toronto, Ontario--(Newsfile Corp. - February 9, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), today announced it has initiated a feasibilit...
News, Short Squeeze, Breakout and More Instantly...
AWAKN LIFE SCIENCES CORP. Company Name:
AWKN:CC Stock Symbol:
AQNC Market:
AWAKN LIFE SCIENCES CORP. Website:
Toronto, Ontario--(Newsfile Corp. - July 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing therapeutics for substance use and mental health disorders, with a near-term focus on Alcohol Use Diso...
Toronto, Ontario--(Newsfile Corp. - Le 31 mai/May 2024) - Effective immediately, Awakn Life Sciences Corp. will be reinstated for trading. The Company has rectified the situation that gave rise to the suspension. _________________________________ Avec effet immédiat, Awakn Life Sc...
Toronto, Ontario--(Newsfile Corp. - Le 8 mai/Mai 2024) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or mor...